2025. Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients with Type 2 Diabetes: Single-Blind Interventional Study with Placebo Control at Tertiary Care Setting Quetta. Life and Science. 6, 4 (Oct. 2025), 06. DOI:https://doi.org/10.37185/LnS.1.1.870.